Pharmaceuticals
The companies featured on PressReleaseFinder are active in several industries.
3 Nov 2014
SpecialChem launches new websites centered on Universal Selectors for richer and faster selection of chemicals and materials
Paris, France, November 3, 2014 - SpecialChem announces the launch of completely revamped websites revolving around its Universal Selectors for chemicals and materials. The goal of the new Universal Selectors is to collaboratively gather all chemicals and materials in the world and provide the knowledge to select them.
25 Oct 2014
AVERY DENNISON LANZA PRODUCTO DE GRAN VERSATILIDAD
Medellín, Colombia - Octubre 2014 - Avery Dennison, lider mundial en materiales para etiquetas y empaque, presenta esta nueva solución para Colombia.
Muttenz, October 23, 2014 - Clariant, a world leader in specialty chemicals, recently hosted the Drug and Pharmaceutical Committee of the Institute of Packaging Professionals (IoPP) at its production facility in Belen, New Mexico.
Shanghai, September 11, 2014 – Clariant, a world leader in specialty chemicals, continues to demonstrate that it is possible to combine creativity with enhanced protection and processing performance for healthcare applications with its sector-dedicated MEVOPUR® polymer and packaging solutions at MedTec China, Shanghai (booth D201) 25th -26th September 2014 . MEVOPUR color and performance additives are developed and produced at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia to ensure ‘Controlled, Consistent and Compliant’ innovations for the industry. 
Launched in January 2013, the Innovative Medicines Initiative (IMI)-funded* project gives the entire European research community access to a unique, high quality and extensive lead-like compound library, the Joint European Compound Library (JECL). The European Lead Factory also offers the cutting-edge infrastructure and expertise needed to screen against novel biological targets. This creates an outstanding opportunity to discover novel compounds, summarized in a so-called Qualified Hit List (QHL), for use either as pharmacological tools or as the starting points for drug discovery projects.